Cargando…
Management of Chemotherapy-Induced Left Ventricular Dysfunction and Heart Failure in Patients With Cancer While Undergoing Cancer Treatment: The MD Anderson Practice
Chemotherapy-induced cardiotoxicity resulting in heart failure (HF) is one of the most dreaded complications of cancer therapy that can significantly impact morbidity and mortality. With a high prevalence of cardiovascular disease in cancer patients, the risk of developing HF is significantly increa...
Autor principal: | Fadol, Anecita P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883083/ https://www.ncbi.nlm.nih.gov/pubmed/29644219 http://dx.doi.org/10.3389/fcvm.2018.00024 |
Ejemplares similares
-
Validation of the Spanish version of the MD Anderson symptom inventory – heart failure (MDASI-HF-Spanish) module
por: Fadol, Anecita, et al.
Publicado: (2019) -
Pregnancy in a Patient With Cancer and Heart Failure: Challenges and Complexities
por: Fadol, Anecita P., et al.
Publicado: (2012) -
Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation
por: Abdelshafy, Mahmoud, et al.
Publicado: (2022) -
Heart rate variability as an indicator of left ventricular systolic dysfunction
por: Shehab, Abdulla, et al.
Publicado: (2009) -
Electrocardiographic Features of Left Ventricular Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Systematic Review
por: Van Ommen, Anne-Mar, et al.
Publicado: (2021)